A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with ‘sandwich’ therapy

Authors

  • Chunli Yang State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
  • Li Zhang National Cancer Center/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
  • Ming Jiang Department of Oncology, West China Hospital of Sichuan University, Chengdu, China
  • Li Xie Department of Oncology, West China Hospital of Sichuan University, Chengdu, China
  • Hong Zhang Department of Oncology, West China Hospital of Sichuan University, Chengdu, China
  • Weiping Liu Department of Pathology, West China Hospital of Sichuan University, Chengdu, China
  • Wenyan Zhang Department of Pathology, West China Hospital of Sichuan University, Chengdu, China
  • Sha Zhao Department of Pathology, West China Hospital of Sichuan University, Chengdu, China
  • Liqun Zou Department of Oncology, West China Hospital of Sichuan University, Chengdu, China

DOI:

https://doi.org/10.1080/0284186X.2022.2044516

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2022-05-04

How to Cite

Yang, C., Zhang, L., Jiang, M., Xie, L., Zhang, H., Liu, W., … Zou, L. (2022). A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with ‘sandwich’ therapy. Acta Oncologica, 61(5), 611–614. https://doi.org/10.1080/0284186X.2022.2044516

Issue

Vol. 61 No. 5 (2022): Acta Oncologica

Section

Articles